Slideshow

13 Psychiatric Drugs With Novel Mechanisms: A Timeline

Author(s):

John J. Miller, MD

Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.

Related Videos
40 years
Have A Nice Day Photo/AdobeStock
Tasphong/AdobeStock
Andrey/AdobeStock
brain research
pills
brain
depression
brain depression
Related Content
clinical trial
April 21st 2025

MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder

Grace Koennecke
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
antidepressants
April 8th 2025

No, Your Patients Are Not Wrong: Sometimes Antidepressant Side Effects Do Not Get Better

Colin Xu, PhD Thomas T. Kim, PhD
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
cognition fog
March 24th 2025

When the Fog Doesn’t Lift: Targeting Cognitive Dysfunction in Depression

Susannah Murphy, DPhil, MA, MSc
depression
March 19th 2025

Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression

Justin Allen, MD Lalangi Marasinghe, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
© 2025 MJH Life Sciences

All rights reserved.